The risk of defects in the neural tube caused by valproic acid and carbamazepine

Objective. To determine the risk, if any, of carbamazepine and valproic acid use on the foetus with respect to neural tube defects. Materials and methods. Databases such as MEDLINE, EMBASE, SCISEARCH, The Cochrane Library and LILACS were consulted to have access to published literature from January...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2005

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23129

Acceso en línea:

https://repository.urosario.edu.co/handle/10336/23129

Palabra clave:

Carbamazepine
Valproic acid
Anticonvulsive agent
Carbamazepine
Valproic acid
Article
Clinical trial
Cochrane library
Embase
Epilepsy
Human
Medline
Meningomyelocele
Meta analysis
Monotherapy
Neural tube defect
Prenatal exposure
Risk assessment
Systematic review
Treatment duration
Chemically induced disorder
Congenital malformation
Drug effect
Female
Fetus
Neural tube defect
Pregnancy
Prenatal exposure
Risk
Risk factor
Anticonvulsants
Carbamazepine
Female
Fetus
Humans
Neural tube defects
Odds ratio
Pregnancy
Prenatal exposure delayed effects
Risk factors
Valproic acid
Carbamazepine
Meta-analysis
Neural tube defects
Prenatal exposure delayed effects
Relative risk
Valproic acid

Rights

License

Abierto (Texto Completo)